ロード中...
Carboplatin and Paclitaxel with vs without Bevacizumab in Older Patients with Advanced Non-Small-Cell Lung Cancer
CONTEXT: A randomized trial demonstrates that adding bevacizumab to carboplatin and paxlitaxel improves survival in advanced non-small-cell lung cancer (NSCLC). OBJECTIVE: To examine whether adding bevacizumab to carboplatin and paclitaxel chemotherapy is associated with improved survival in the NSC...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3418968/ https://ncbi.nlm.nih.gov/pubmed/22511687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2012.454 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|